Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Glycostem Initiates Trial to Evaluate oNKord for AML

americanpharmaceuticalreviewDecember 08, 2020

Tag: Glycostem Therapeutics , oNKord , AML

PharmaSources Customer Service